C-reactive protein elevation independently influences the procedural success of percutaneous balloon mitral valve commissurotomy

American Heart Journal

Volumn 146, Issue 6, 2003, Pages 1099-1104

  Krasuski, Richard A ^a   Bush, Anneke ^a   Kay, Joseph E ^b   Mayes Jr , Charles E ^b   Wang, Andrew ^b   Fleming, Judy ^b   Pierce, Cynthia ^b   Kisslo, Katherine B ^b   Harrison, J Kevin ^b   Bashore, Thomas M ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE COMMISSUROTOMY; MITRAL VALVE STENOSIS; PERCUTANEOUS BALLOON MITRAL VALVE COMMISSUROTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RHEUMATIC HEART DISEASE; TREATMENT OUTCOME;

EID: 10744232675     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00506-4     Document Type: Article

References (41)

1. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-8.
2. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007-11.
3. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000;35:469-76.
4. Legouffe E, Rodriguez C, Picot MC, et al. C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin's lymphoma. Leuk Lymphoma 1998;31:351-7.
5. Miyata Y, Koga S, Nishikido M, et al. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma. Urology 2001;58:161-4.
6. Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998;176:335-8.
7. O'Gorman P, McMillan DC, McArdle CS. Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer 2000;37:36-40.
8. Edep ME, Shirani J, Wolf P, Brown DL. Matrix matalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol 2000;9:281-6.
9. Galante A, Pietroiusti A, Vellini M, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001;38:1078-82.
10. Novaro GM, Tiong IY, Pearce GL, et al. Effect of hydoxymethylglutaryl coenzyme inhibitors on the progression of calcific aortic stenosis. Circulation 2001;104:2205-9.
11. Schoen FJ, St. John Sutton M. Contemporary pathologic considerations in valvular disease. In: Virmani B, Atkinson JB, Feuoglio JJ, editors. Cardiovascular pathology. Philadelphia: Saunders; 1991. p. 334-53.
12. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204.
13. Mawhorter SD, Lauer MA. Is atherosclerosis an infectious disease? Cleve Clin J Med 2001;68:449-58.
14. Epstein SE. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ Res 2002; 90:2-4.
15. Guedez Y, Kotby A, El-Demellawy M, et al. HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation 1999;99: 2784-90.
16. Yetkin ER, Erbay AR, Ileri M, et al. Levels of circulating adhesion molecules in rheumatic mitral stenosis. Am J Cardiol 2001;88: 1209-11.
17. Sellers RD, Levy MJ, Amplatz K, Lillehei CW. Left retrograde cardio-angiography in acquired cardiac disease: technique, indications, and interpretation in 700 cases. Am J Cardiol 1964;14:437-47.
18. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988;60:299-308.
19. Feldman T, Herrmann HC, Inoue K. Technique of percutaneous transvenous mitral commissurotomy using the Inoue balloon catheter. Cathet Cardiovasc Diagn 1994;Suppl 2:26-34.
20. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988;60:299-308.
21. Hatle L, Angelsen B, Tromsdal A. Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound. Circulation 1979;60:1096-104.
22. Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987;75:175-83.
23. Stollerman GH. Rheumatologic streptococci and autoimmunity. Clin Immunol Immunopathol 1991;61:131-42.
24. Wallace MR, Garst PD. The return of acute rheumatic fever in young adults. JAMA 1989;262:2257-61.
25. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and risks of cardiovascular disease in apparently healthy men. N Engl J Med 1997;1997:973-9.
26. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98: 731-3.
27. Biasucci LM, Liuzzo G, Grillo RL, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999;99:855-60.
28. Gheno G, Libardoni M, Zeppellini R, Cucchini F. C-reactive protein on admission as a predictor of in-hospital death in the elderly with acute myocardial infarction. Cardiologia 1999;44:1023-8.
29. Morrow DA, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A sub-study. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998;31:1460-5.
30. Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 2001;32:917-24.
31. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-reactive protein and outcome after ischemic stroke. Stroke 1999;30:981-5.
32. Kaneko K, Kanda T, Yamauchi Y, et al. C-reactive protein in dilated cardiomyopathy. Cardiology 1999;91:215-9.
33. Listing J, Rau R, Muller B, et al. HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. Berlin Collaborating Rheumatological Study Group. J Rheumatol 2000;27: 2100-9.
34. Pethig K, Heublein B, Kutschka I, Haverich A. Systemic inflammatory response in cardiac allograft vasculopathy: high-sensitive C-reactive protein is associated with progressive luminal obstruction. Circulation 2000;102(19 Suppl 3):III233-6.
35. Eisenberg MS, Chen HJ, Warshofsky MK, et al. Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients. Circulation 2000;102:2100-4.
36. Erlandsen EJ, Randers E. Reference interval for serum C-reactive protein in healthy blood donors using the Dade Behring N Latex CRP mono assay. Scand J Clin Lab Invest 2000;60:37-43.
37. Primatesta P, Falaschetti E, Poulter NR. Influence of hormone replacement therapy on C-reactive protein: population-based data. J Cardiovasc Risk 2003;10:57-60.
38. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347:1557-65.
39. Iung B, Cormier B, Ducimetiere P, et al. Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. Circulation 1996;94:2124-30.
40. Buffon A, Liuzzo G, Biasucci LM, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999;34:1512-21.
41. Boeken U, Feindt P, Zimmermann N, et al. Increased preoperative C-reactive protein (CRP)-values without signs of an infection and complicated course after cardiopulmonary bypass (CPB)-operations. Eur J Cardiothorac Surg 1998;13:541-5.